Amgen Price Target Raised by Scotiabank to $500

Amgen's price target has been raised by Scotiabank to $500 from $450. This change was made without any specific date or timeframe provided for when this new target will take effect.

The backtested performance of TipRanks Smart Score shows a strategy not historically offered to investors, with past results that may not be indicative of future actual results.

It's essential to note that these backtested results reflect the retroactive application of a model constructed on historical data and are subject to losses. Changes in assumptions can have a material impact on the returns presented.